STAT

GSK myeloma medicine improves survival in trial, another step in the drug’s revival

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — A blood cancer treatment from GSK helped patients live longer in ...
GEN

GSK to Acquire Rapt for $2.2B, Adding Food Allergy Candidate to Pipeline

GlaxoSmithKline (GSK) researchers at work in an R&D laboratory at the company's Stevenage, U.K., site. GSK has agreed to acquire Rapt Therapeutics for $2.2 billion, in a deal intended to bolster the ...

GSK granted FDA nod for Lynavoy for itch associated with rare liver disorder

GSK (GSK) stock is in focus as the company wins FDA nod for Lynavoy, the first U.S. treatment for cholestatic pruritus in ...
The Boston Globe

GSK buys liver drug from Boston Pharmaceuticals for up to $2 billion

GSK agreed to buy an experimental medicine from a Cambridge biotech for as much as $2 billion to shore up its drug pipeline and muscle into the promising field of liver therapies. The treatment, made ...
Yahoo

FDA, in unusual step, aims to repurpose old GSK drug as autism treatment

Add Yahoo as a preferred source to see more of our stories on Google. A GSK logo is seen on the side of an office building in Poznan, Poland. As part of its fight against autism, the Trump ...
STAT

GSK blood cancer therapy, once pulled from the market, is approved in the U.K.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on ...
Yahoo

FDA clears return of GSK’s once-withdrawn multiple myeloma drug

Add Yahoo as a preferred source to see more of our stories on Google. A GSK logo is seen on the side of an office building in Poznan, Poland. (Getty Images) This story was originally published on ...
Business Wire

GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...
Morningstar

Helix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine Development

SAN MATEO, Calif., Jan. 7, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics company, today announced a multi-year strategic collaboration with GSK, the global biopharma company. This ...

GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript

Goldman Sachs 9th Annual Biopharma Innovation Summit March 26, 2026 5:00 AM EDTCompany ParticipantsKaivan Khavandi - Senior VP, Global Head ...

Broker reiterates GSK 'buy' as court ruling lifts vaccine cloud

Shore Capital has reiterated its buy recommendation on GSK PLC (LSE:GSK, NYSE:GSK) with a fair value of 2,500p, arguing the ...
PharmiWeb

Alfasigma acquires GSK gastrointestinal brand to expand global reach

Alfasigma is acquiring a gastrointestinal medicine from GSK to strengthen its specialty portfolio and expand global reach, ...